Neutrophil elastase-mediated myoepithelial loss is a therapeutic vulnerability in ductal carcinoma in situ progression
Authors:
- Tarek TaifourTTTarek Taifour
- Yu GuYGYu Gu
- Adéline MasséAMAdéline Massé
- Xiwei MengXMXiwei Meng
- Clarisse Dane EchavezCEClarisse Dane Echavez
- Dongmei ZuoDZDongmei Zuo
- Virginie Sanguin-GendreauVSVirginie Sanguin-Gendreau
- Anne BlouinABAnne Blouin
- Adda-Lee Graham-PaquinAGAdda-Lee Graham-Paquin
- Miranda AddieMAMiranda Addie
- Emilie SolymossESEmilie Solymoss
- Bin XiaoBXBin Xiao
Open Access
- 11 September 2026
- journal article
- Published by Elsevier in Cell Reports Medicine
- Vol. 7 (10)
Abstract
No abstract availableFunding Information
- Cancer Research Society (1281449)
- Canadian Cancer Society (Impact Grant)
- Fonds de recherche du Québec
- Terry Fox Research Institute (Program Project Grant)
- Canadian Institutes of Health Research (148373)
- Canadian Institutes of Health Research (PLL-185690)
- Canadian Institutes of Health Research (PJT-190027)
- Santé
- Fondation du cancer du sein du Québec
- Canadian Cancer Society
This publication has 63 references indexed in Scilit:
- Targeting neutrophil elastase is a promising direction for future cancer treatmentDiscover Oncology, 2024
- An extracellular matrix stiffness-induced breast cancer cell transcriptome resembles the transition from ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC)Biochemical and Biophysical Research Communications, 2023
- Loss of myoepithelial calponin‐1 characterizes high‐risk ductal carcinoma in situ cases, which are further stratified by T cell compositionMolecular Carcinogenesis, 2020
- Breast Cancer: Current Perspectives on the Disease Status2019
- Morphologic and Molecular Features of Breast Ductal Carcinoma in SituThe American Journal of Pathology, 2019
- Breaking through to the Other Side: Microenvironment Contributions to DCIS Initiation and ProgressionJournal of Mammary Gland Biology and Neoplasia, 2018
- Characterizing the immune microenvironment in high-risk ductal carcinoma in situ of the breastBreast Cancer Research and Treatment, 2016
- Overview of Genetically Engineered Mouse Models of Distinct Breast Cancer SubtypesCurrent Protocols in Pharmacology, 2016
- Myoepithelial Cell Differentiation Markers in Ductal Carcinoma in Situ ProgressionThe American Journal of Pathology, 2015
- An international comparison of male and female breast cancer incidence ratesInternational Journal of Cancer, 2012